43
Participants
Start Date
June 27, 2019
Primary Completion Date
December 1, 2020
Study Completion Date
January 29, 2021
Azeliragon
Azeliragon 5 mg capsule administered orally, once daily
Placebo
Matching placebo capsule administered orally, once daily
Neurological Associates of Long Island, Lake Success
Clarity Clinical Research, East Syracuse
Wake Forest School of Medicine, Winston-Salem
Raleigh Neurology Associates, Raleigh
ANI Neurology dba Alzheimer's Memory Center, Charlotte
NeuroStudies.net LLC, Decatur
Emory Alzheimer's Clinical Research Unit, Atlanta
Progressive Medical Research, Port Orange
Charter Research, Lady Lake
Jacksonville Center for Clinical Research, Jacksonville
Emerald Coast Center for Neurological Disorders, Pensacola
ClinCloud, Maitland
Synexus Clinical Research US, Orlando
Brain Matters Research, Delray Beach
Alzheimer's Research and Treatment Center, Lake Worth
JEM Research Institute, Atlantis
The Roskamp Institute, Sarasota
Brain Matters Research, Stuart
Memory Center / Hattiesburg Clinic, Hattiesburg
The Ohio State University, Columbus
IU Health Partners, Adult Neurology Clinic, Indianapolis
Millennium Psychiatric Associates, St Louis
Tucson Neuroscience Research, Tucson
Summit Research Network, Portland
Center for Cognitive Health, Portland
Institute for Neurodegenerative Disorders, New Haven
The Cognitive and Research Center of New Jersey, Springfield
Okanagan Clinical Trials Ltd., Kelowna
True North Clinical Research Inc., Halifax
True North Clinical Research Inc., Kentville
Recherches Neuro-Hippocampe, Ottawa
Recherches Neuro-Hippocampe Inc., Gatineau
Q&T Research Sherbrooke Inc, Sherbrooke
Lead Sponsor
vTv Therapeutics
INDUSTRY